Cargando…
Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction: study protocol for a randomized controlled trial
BACKGROUND: Treatment with beta-blockers is currently recommended after myocardial infarction (MI). The evidence relies on trials conducted decades ago before implementation of revascularization and contemporary medical therapy or in trials enrolling patients with heart failure or reduced left ventr...
Autores principales: | Kristensen, Anna Meta Dyrvig, Bovin, Ann, Zwisler, Ann Dorthe, Cerquira, Charlotte, Torp-Pedersen, Christian, Bøtker, Hans Erik, Gustafsson, Ida, Veien, Karsten Tange, Thomsen, Kristian Korsgaard, Olsen, Michael Hecht, Larsen, Mogens Lytken, Nielsen, Olav Wendelboe, Hildebrandt, Per, Foghmar, Sussie, Jensen, Svend Eggert, Lange, Theis, Sehested, Thomas, Jernberg, Tomas, Atar, Dan, Ibanez, Borja, Prescott, Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245032/ https://www.ncbi.nlm.nih.gov/pubmed/32446298 http://dx.doi.org/10.1186/s13063-020-4214-6 |
Ejemplares similares
-
Unstable Angina as a Component of Primary Composite Endpoints in Clinical Cardiovascular Trials: Pros and Cons
por: Kristensen, Anna Meta Dyrvig, et al.
Publicado: (2022) -
External validity of randomized clinical trial studying preventing depressive symptoms following acute coronary syndrome
por: Madsen, Michael Tvilling, et al.
Publicado: (2021) -
Heart Rehabilitation for All (HeRTA): Protocol for a feasibility study and pilot randomized trial
por: Birke, Hanne, et al.
Publicado: (2022) -
The patient education strategy “learning and coping” improves adherence to cardiac rehabilitation in primary healthcare settings: a pragmatic cluster-controlled trial
por: Pedersen, Charlotte Gjørup, et al.
Publicado: (2022) -
Can municipality-based post-discharge follow-up visits including a general practitioner reduce early readmission among the fragile elderly (65+ years old)? A randomized controlled trial
por: Thygesen, Lau Caspar, et al.
Publicado: (2015)